Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_673ff14039b5eb08274dfb83d39d69e6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_00f47fbd9850d3ae1b9fe93f81286561 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6b84c8b7f0de84fb9c1e31882f68393d http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3d0e0f62305dbeffd80af47957045cf0 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1816 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-505 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-505 |
filingDate |
2006-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2014-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25e81eb40ba7764752a9749cea1e545e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1c6a6df021ff287f311f4cc37d66418 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7689d1a3b979224ad9b2eced54eac71 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7495337294d12342e74669a1dd778c4f |
publicationDate |
2014-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-8653028-B2 |
titleOfInvention |
Erythropoietin-derived short peptide and its mimics as immuno/inflammatory modulators |
abstract |
The present invention provides isolated stabilized EPO-derived peptides and their mimics that protect against tissue damage in subjects having diverse forms of neural and non-neural organ system injury, pharmaceutical compositions containing the isolated stabilized EPO-derived peptides, methods for treating symptoms of a disease, disorder or condition having an inflammatory or an autoimmune component in a subject in need thereof, and methods for downregulating immune mediator activity in a subject in need thereof. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10100096-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015152156-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9580465-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9340598-B2 |
priorityDate |
2005-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |